Search results
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong...
Benzinga via Yahoo Singapore Finance· 2 days agoOn Thursday, Sanofi SA (NASDAQ:SNY) reported a second-quarter business operating income of 2.8...
Sanofi: Q2 Earnings Snapshot
Associated Press Finance via Yahoo Singapore Finance· 2 days agoPARIS (AP) — PARIS (AP) — Sanofi (SNY) on Thursday reported second-quarter earnings of $1.2 billion. On a per-share basis, the company said it had profit of 48 cents. Earnings ...
European shares fall as earnings deluge disappoints
Reuters via Yahoo Singapore Finance· 2 days agoSwiss contract drug manufacturer Lonza gained 7.1% after reporting a smaller-than-expected decline in first-half profit, while Sanofi jumped 4.2% after...
Sanofi lifts FY guidance after strong Q2 results
Investing.com via Yahoo Singapore Finance· 2 days agoInvesting.com - Sanofi (NASDAQ:SNY) stock rose Thursday after the French drugmaker lifted its full-year profit forecast after strong second-quarter results, based on strong ...
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
Reuters via Yahoo Singapore Finance· 2 days ago(Reuters) -Sanofi on Thursday raised its full-year profit outlook after strong demand for...
Roche lifts 2024 profit guidance on strong drug sales
Reuters via Yahoo Singapore Finance· 2 days agoFRANKFURT (Reuters) -Roche on Thursday raised its full-year earnings forecast after exceeding...
Morning Bid: Stock rout spreads beyond tech
Reuters via Yahoo Singapore Finance· 2 days agoThe global equity sell-off looks set to extend into Europe on Thursday although the region may be spared the carnage in parts of Asia, where Japan's...
Biden's speech, Ford's miss, European earnings - what's moving markets
Investing.com via Yahoo Singapore Finance· 2 days agoThe tech-led selloff looks set to continue Thursday, while Ford has also disappointed with a second-quarter profit miss. President Joe Biden addressed the nation on Wednesday for the first time ...
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage...
Benzinga via Yahoo Singapore Finance· 4 days agoOn Tuesday, Merck & Co Inc (NYSE:MRK) shared topline results from its Phase 2b/3 clinical trial...
The global M&A market’s big-deal bravado is losing steam as rates stay high in 2024
Fortune via Yahoo Singapore Finance· 4 days agoHowever, some of this year’s transactions fell apart at the first hurdle, as shareholders started to...